Where is MI-VAD located?

MI-VAD is headquartered in Rochester, United States.

Who is the current CEO of MI-VAD?

Sudhir Kushwaha of MI-VAD. They have also founded 1 company.

How many employees does MI-VAD have?

As of May 31, 2026, the latest employee count at MI-VAD is 2.

Is MI-VAD a funded company?

MI-VAD is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does MI-VAD rank among its competitors?

MI-VAD ranks 84th amongst 99 active competitors, of which 58 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was FineHeart, which secured $56M in Jan, 2026.

Who are the top competitors of MI-VAD?

MI-VAD's top competitors include CVRx, Impulse Dynamics and CorWave. Among them, FineHeart secured the most recent funding round in January, 2026.

MI-VAD - 2026 Company Profile, Team & Competitors

Company Details

Developer of ventricular assist device to treat heart failure. The company developed a revolutionary mechanical blood circulatory device or blood pump known as an MI-VAD minimally invasive ventricular assist device (VAD) for heart failure patients.

Website: mivadinc.com
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2017

Location

Rochester, United States

Stage

Unfunded

Ranked

84^th among 99 active competitors

Employee Count

2 as on May 31, 2026

Similar Companies

CVRx & 124 more

View MI-VAD's full profile

MI-VAD has not raised any funding rounds yet.

The founders of MI-VAD is Sudhir Kushwaha. Sudhir Kushwaha is the CEO of MI-VAD.

Here are the details of MI-VAD's key team members:

Sudhir Kushwaha: Co-Founder & CEO of MI-VAD.
Contact Info: 1 email address

View details of MI-VAD's Founder profiles and Board Members

MI-VAD's employee count trend

MI-VAD has 2 employees as of May 26. Here is MI-VAD's employee count trend over the years:

Uncover MI-VAD's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MI-VAD include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of MI-VAD, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CVRx 2001, Minneapolis (United States), Public	Developer of implantable technology for hypertension and heart failure	$394M	Johnson & Johnson Innovation – JJDC, New Enterprise Associates ... & 20 others	68/100
2nd	Impulse Dynamics 1998, Marlton (United States), Series F	Provider of implantable device for treatment of chronic heart failure	$685M	Perceptive Advisors, Amzak Health & 16 others	64/100
3rd	CorWave 2011, Paris (France), Series C	Developer of implantable blood pumps for the treatment of heart failure	$127M	Novo Holdings, Sofinnova Partners & 11 others	61/100
4th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100
5th	SynCardia 2001, Tucson (United States), Public	Artificial heart	$72M	Athyrium Capital Management, SWK Holdings ... & 5 others	60/100
6th	FineHeart 2010, Pessac (France), Series C	Developer of an implantable cardiovascular device for treating heart failures	$51.9M	Verve Ventures, Broadview Ventures & 16 others	57/100
7th	Restore Medical 2016, Tel Aviv (Israel), Series B	Catheter-delivered implant for treatment of congestive heart failure	$32M	European Innovation Council, Pitango & 3 others	57/100
8th	Reprieve Cardiovascular 2018, Milford (United States), Series B	Developer of decongestion management solution for acute decompensated heart failure patients	$150M	Deerfield, Arboretum Ventures & 8 others	56/100
9th	Bivacor 2008, Houston (United States), Series B	Developer of ventricular assist device (VAD)	$28M	Cormorant Asset Management, One Ventures & 3 others	56/100
10th	Procyrion 2005, Houston (United States), Series E	Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome	$114M	Fannin Innovation Studio, Scientific Health Development ... & 4 others	54/100
84th	MI-VAD 2017, Rochester (United States), Unfunded	Developer of ventricular assist device to treat heart failure	-	-	25/100